Swayampakula Ramakanth's Stock Ratings

HC Wainwright & Co. Analyst

Swayampakula Ramakanth is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

11.2%

Smart Score

67.8%

Overall Average Return Percentile

62nd

Number of Ratings

281
Buy NowGet Alert
05/17/2024EDAPBuy Now
Edap TMS
$7.44155.38% → $19ReiteratesBuy → BuyGet Alert
05/16/2024CELCBuy Now
Celcuity
$17.6552.97% → $27ReiteratesBuy → BuyGet Alert
05/16/2024ASXCBuy Now
Asensus Surgical
$0.2632.48% → $0.35ReiteratesNeutral → NeutralGet Alert
05/16/2024LFWDBuy Now
Rewalk Robotics
$5.20150%$9 → $13MaintainsBuyGet Alert
05/16/2024PYXSBuy Now
Pyxis Oncology
$4.1668.27% → $7ReiteratesBuy → BuyGet Alert
05/16/2024DNTHBuy Now
Dianthus Therapeutics
$26.2552.38% → $40Initiates → BuyGet Alert
05/15/2024IPHABuy Now
Innate Pharma
$2.56349.22% → $11.5ReiteratesBuy → BuyGet Alert
05/15/2024DCTHBuy Now
Delcath Systems
$7.50193.27%$20 → $22MaintainsBuyGet Alert
05/15/2024ABSIBuy Now
Absci
$4.6849.57% → $7ReiteratesBuy → BuyGet Alert
05/15/2024OCGNBuy Now
Ocugen
$1.94260.21% → $7ReiteratesBuy → BuyGet Alert
05/15/2024PGENBuy Now
Precigen
$1.41325.53% → $6ReiteratesBuy → BuyGet Alert
05/14/2024LPTXBuy Now
Leap Therapeutics
$2.8890.97%$7 → $5.5MaintainsBuyGet Alert
05/13/2024JANXBuy Now
Janux Therapeutics
$47.0333.96%$50 → $63MaintainsBuyGet Alert
05/13/2024ITOSBuy Now
ITeos Therapeutics
$17.54162.26%$44 → $46MaintainsBuyGet Alert
05/13/2024INABBuy Now
IN8bio
$1.021125.49%$14 → $12.5MaintainsBuyGet Alert
05/10/2024QSIBuy Now
Quantum-Si
$1.79123.46% → $4ReiteratesBuy → BuyGet Alert
05/09/2024VCELBuy Now
Vericel
$47.3116.25%$53 → $55MaintainsBuyGet Alert
05/03/2024BCYCBuy Now
Bicycle Therapeutics
$22.18147.97% → $55ReiteratesBuy → BuyGet Alert
05/02/2024CORTBuy Now
Corcept Therapeutics
$28.2841.44%$38 → $40MaintainsBuyGet Alert
05/01/2024MDXGBuy Now
MiMedx Group
$7.8340.4% → $11ReiteratesBuy → BuyGet Alert
05/01/2024CYTHBuy Now
Cyclo Therapeutics
$1.36120.59% → $3Initiates → BuyGet Alert
04/30/2024XFORBuy Now
X4 Pharmaceuticals
$0.94431.91%$3 → $5MaintainsBuyGet Alert
04/30/2024EKSOBuy Now
Ekso Bionics Holdings
$1.37629.93%$9.25 → $10MaintainsBuyGet Alert
04/23/2024CORTBuy Now
Corcept Therapeutics
$28.2834.37% → $38ReiteratesBuy → BuyGet Alert
04/15/2024LFWDBuy Now
Rewalk Robotics
$5.2073.08% → $9ReiteratesBuy → BuyGet Alert
04/11/2024IPHABuy Now
Innate Pharma
$2.56349.22% → $11.5ReiteratesBuy → BuyGet Alert
04/10/2024ALXOBuy Now
ALX Oncology Holdings
$14.5337.65% → $20ReiteratesBuy → BuyGet Alert
04/10/2024INABBuy Now
IN8bio
$1.021272.55% → $14ReiteratesBuy → BuyGet Alert
04/10/2024PYXSBuy Now
Pyxis Oncology
$4.1668.27% → $7ReiteratesBuy → BuyGet Alert
04/09/2024ELEVBuy Now
Elevation Oncology
$3.6166.2% → $6ReiteratesBuy → BuyGet Alert

Recent Analyst Stock Rating News

The Analyst Verdict: Absci In The Eyes Of 6 Experts
4 Analysts Assess Ocugen: What You Need To Know
Analyst Ratings For Janux Therapeutics
Critical Insights From Vericel Analyst Ratings: What You Need To Know
The Analyst Verdict: Corcept Therapeutics In The Eyes Of 4 Experts
Key Takeaways From Ocugen Analyst Ratings
A Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analysts
Expert Ratings For Bicycle Therapeutics
Wayfair To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free